Boston/Johnson & Johnson get June 05 patent trial date
This article was originally published in Clinica
The US District Court in Delaware has scheduled a trial for June 2005 in the ongoing drug-eluting stent patent infringement battle between Boston Scientific and Johnson & Johnson unit Cordis. The trial will not address all of the patents cited in the suits that the two firms filed against each other in 2003. It will involve two of the six patents that Boston claims are infringed by Cordis's Cypher sirolimus-coated stent, and the one patent that Cordis claims Boston's Express2 device infringes. Express2 is used as the platform for Boston's Taxus paclitaxel-coated stent.